OVID peer analysis
Ovid Therapeutics (OVID) against its competitors: price, today's move, 1-year return and market value side by side.
OVID and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABEO Abeona Therapeutics | $4.18 | 6.89% | -12.61% | $241.32M |
| LXEO Lexeo Therapeutics | $2.89 | -0.52% | -65.33% | – |
| MGTX MeiraGTx | $9.00 | 5.76% | 2.92% | $904.73M |
| NGNE Neurogene | $25.31 | -1.33% | -13.55% | – |
| RARE Ultragenyx | $15.43 | -0.90% | -49.23% | $1.75B |
| RCKT Rocket Pharmaceuticals | $2.39 | -1.89% | -27.36% | $286.51M |
| STOK Stoke Therapeutics | $27.20 | 4.33% | 4.18% | $1.78B |
| TSHA Taysha Gene Therapies | $4.33 | 5.87% | -0.94% | – |
| VYGR Voyager Therapeutics | $1.83 | 6.40% | -58.89% | $115.23M |
| WVE Wave Life Sciences | $3.34 | 3.73% | -58.86% | $713.97M |
| OVID Ovid Therapeutics | $2.86 | 10.85% | 90.23% | $535.12M |
- OVID's peers: ABEO (Abeona Therapeutics), LXEO (Lexeo Therapeutics), MGTX (MeiraGTx), NGNE (Neurogene), RARE (Ultragenyx), RCKT (Rocket Pharmaceuticals), STOK (Stoke Therapeutics), TSHA (Taysha Gene Therapies).
Updated 2026-11-07 11:53 UTC